hcrn-gu16-260: nivolumab and salvage nivolumab-ipilimumab in patients with advanced rcc
Published 2 years ago • 136 plays • Length 5:44Download video MP4
Download video MP3
Similar videos
-
1:52
hcrn gu16-260: nivolumab and salvage nivolumab ipilimumab in treatment-naïve patients with adv...
-
8:26
front-line therapy with nivolumab and salvage nivolumab ipilimumab in patients with advanced rcc
-
8:07
hcrn gu16-260: nivolumab, salvage nivo/ipi in advanced clear cell rcc
-
6:16
treatment-free survival results of nivolumab and salvage nivolumab ipilimumab for accrcc
-
5:52
nivolumab and salvage nivolumab plus ipilimumab for arcc
-
5:19
fraction-rcc: evaluating nivolumab plus ipilimumab in patients with treatment-refractory advance...
-
1:55
investigating responses to nivolumab and ipilimumab in advanced rcc
-
6:00
clinical trial for advanced kidney cancer: hcrn gu16-260
-
9:09
nivolumab with alternatively scheduled ipilimumab in first-line treatment of advanced rcc
-
2:08
nivolumab with ipilimumab for mrcc
-
5:42
asco: nivolumab followed by salvage ipilimumab plus nivolumab for patients with advanced rcc
-
1:27
dr. hammers on nivolumab/ipilimumab data in rcc
-
1:56
nivolumab and ipilimumab for advanced bcvh
-
1:08
dr. motzer on nivolumab/ipilimumab activity in rcc
-
0:39
dr. lopes on the fda approval of nivolumab/ipilimumab in nsclc
-
6:01
metastatic rcc: using frontline ipilimumab/nivolumab
-
5:10
checkmate 214: patterns of progression with nivolumab plus ipilimumab versus sunitinib for rcc
-
1:43
nivolumab, ipilimumab and panitumumab in mcrc
-
1:34
fda approval of frontline nivolumab/ipilimumab combo in rcc